Development
Lexicon Pharmaceuticals, Inc.
LXRX
$1.15
$0.109.52%
NASDAQ
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 60.37% | 314.31% | 22.47% | 59.50% | 12.64% |
| Total Receivables | 715.38% | 1,914.71% | 605.41% | 100.00% | 69.57% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 52.11% | 111.46% | 76.96% | 14.65% | -7.93% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 60.63% | 306.36% | 23.88% | 58.42% | 12.14% |
|
|
|||||
| Total Current Assets | 60.63% | 306.36% | 23.88% | 58.42% | 12.14% |
| Net Property, Plant & Equipment | -3.19% | 193.38% | 169.26% | 158.06% | 113.62% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 44.24% | 181.97% | 19.49% | 41.92% | 11.23% |
|
|
|||||
| Total Accounts Payable | 27.68% | 42.93% | 10.62% | 13.58% | 12.97% |
| Total Accrued Expenses | 148.74% | 64.07% | 1.45% | -3.34% | -42.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.18% | 63.62% | 37.34% | 18.55% | -88.95% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 74.90% | 54.84% | 7.75% | 4.74% | -46.14% |
|
|
|||||
| Total Current Liabilities | 74.90% | 54.84% | 7.75% | 4.74% | -46.14% |
| Long-Term Debt | 317.36% | 317.98% | 108.05% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 0.09% | 447.11% | 396.72% | 355.80% | 267.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 187.35% | 214.17% | 71.73% | 231.02% | 33.42% |
|
|
|||||
| Common Stock & APIC | 9.02% | 15.35% | 6.64% | 6.24% | 6.19% |
| Retained Earnings | -10.12% | -8.51% | -7.31% | -6.85% | -6.64% |
| Treasury Stock & Other | -17.48% | -35.01% | -45.28% | 66.94% | 66.08% |
| Total Common Equity | -3.13% | 163.11% | -5.02% | 3.11% | 5.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -3.13% | 163.11% | -5.02% | 3.11% | 5.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -3.13% | 163.11% | -5.02% | 3.11% | 5.43% |
|
|
|||||